Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Lyell Immunopharma

Founders Rick Klausner Scott Boyken

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$46M
Portfolio companies 5
Rounds per year 1.75
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Life Science
  • Health Care
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Lyell Immunopharma:
Typical Co-investors
Lyell Immunopharma is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Lyell Immunopharma:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AGPS Tech Limited China, Hong Kong, Hong Kong Island
Alliance Global Partners New York, New York, United States
Aviv Venture Capital HaMerkaz, Israel, Petah Tiqva
Axa and main incubator -
Bootleg Advisors -
Brand Ventures Cincinnati, Ohio, United States
Chengpu Touzi Beijing, Beijing, China
China South Publishing & Media Group Changsha, China, Jiangsu
Chongrong Investment Beijing, China, Fangshan
Ewing Irrigation & Landscape Supply Arizona, Phoenix, United States
Impact Hub Milan Italy, Lombardia, Milano
Jiankang 160 China, Guangdong, Shenzhen
Jiaxing Xiaoyuan Chuangye Touzi Hehuo Qiye China, Jiaxing, Zhejiang
Ningbo Dongshi Advertising China, Ningbo, Zhejiang
Safe & Rich Venture Capital China, Hangzhou, Zhejiang
Techplace Burlington, Canada, Ontario
Trend Forward Capital California, San Jose, United States
Wanfeng Jinyuan Holding Group China, Shanghai
Zachary Construction -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Outpace Bio

Biotechnology
Health Care
Life Science
Pharmaceutical
$30M31 Mar 2021 Seattle, Washington, United States

Sonoma Pharmaceuticals

Health Care
$70M30 Sep 2020 California, United States

Cero Therapeutics

Biotechnology
Therapeutics
$40M18 Mar 2020 South San Francisco, California, United States

Sonoma BioTherapeutics

Biotechnology
Life Science
Therapeutics
$40M06 Feb 2020 South San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lyell Immunopharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 46M
Rounds per year 1.75
Peak activity year 2020
Lead investments 2
Follow on index 0.29
Exits 1
Group Appearance index 0.86

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Outpace Bio

Biotechnology
Health Care
Life Science
Pharmaceutical
$30M31 Mar 2021 Seattle, Washington, United States

Sonoma Pharmaceuticals

Health Care
$70M30 Sep 2020 California, United States

Cero Therapeutics

Biotechnology
Therapeutics
$40M18 Mar 2020 South San Francisco, California, United States

Sonoma BioTherapeutics

Biotechnology
Life Science
Therapeutics
$40M06 Feb 2020 South San Francisco, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: